Kevin Xu
Free
Kevin Xu - CEO at MEBO International, Skingenix Expert
Kevin Xu Quick Facts
Kevin Xu is the CEO of MEBO International, a Califo ia- and Beijing-based intellectual property management company specializing in applied health systems. He also leads Skingenix, which specializes in skin organ regeneration and the research and development of botanical drug products.
Articles by this expert
SelfGrowth articles and saved writing connected to this expert.
Article
3 Ways to Strengthen International Collaboration for the Good of Your Business
According to a recent survey by Pew Research Center, some 79% of adults expressed an unfavorable opinion of China in 2020. That number rose to 82% in 2022.
Recently added
Article
How Should Nonprofits Incorporate Cryptocurrency?
Cryptocurrency — digital or virtual — is popping up in the nonprofit sphere as a viable donation option. Nonprofits can use cryptocurrency in various ways, such as making payments for goods and services or even holding onto a certain amount of crypto as an investment for the long term.
Recently added
Article
Califo ia Changed Online Charity — Are Nonprofits Prepared?
Change is on the horizon for Califo ia-based charitable donors.
Recently added
Article
Do You Need a Ph.D. to Become a STEM Entrepreneur?
Launching a STEM-based company might seem intimidating if you don’t have an advanced degree in one of the corresponding fields. STEM (science, technology, engineering, and math) industries require extensive study and practice, and you need a strong background in these areas in order to run a successful STEM company. That’s what most people believe, anyway.
Recently added
Article
Biotech, Not Cosmetics, Will Lead Anti-Aging Breakthroughs
Since man first found his first wrinkle, people have been searching for the fountain of youth — or at least the appearance of ete al vigor and vitality. Makeup artists have perfected the technique of masking wrinkles and fine lines, and Botox will freeze your face in place. The anti-aging skin care market will hit $11 billion by 2018. Looking young has long been the holy grail.
Recently added
Article
Welcome to the Future of Anti-Aging Technology
The shift in the medical industry experienced in the past five to 10 years is sizable. When it comes to medical-related technology — such as the ones developed to combat aging — the pivot is even more noticeable. Technology is influencing the anti-aging industry in a couple of ways. First, it affects the attempts to limit the aging process itself, including physical appearance. Second, it’s also swaying the actual pathophysiology of the aging process.
Recently added
Article
How Biotech Can Help Pharma Better Tackle Rare Diseases
Recent outbreaks in the United States, such as Zika and dengue fever in the South, have made it clear that rare infectious diseases know no bounds. Yet, as the threat of infectious diseases rises, government funding for research and development of cures has hit an all-time low, forcing pharmaceutical companies to do more with less.
Recently added